Uncertainty around ELEVIDYS sales impact Sarepta Therapeutics, Inc. Click here to find out why I downgraded SRPT stock to a ...

The National Comprehensive Cancer Network (NCCN) policy summit, “Primary Care and Oncology Collaboration to Improve Patient ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant ...

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Good day, everyone, and welcome to the Syndax First Quarter 2025 ...

A new bone marrow test can help doctors predict risk of leukemia relapse. The test might double survival rates by predicting ...

Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...

Q1 2025 Earnings Call Transcript May 6, 2025 Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.03. Operator: Good day ladies and ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

The information turned up in a lawsuit filed by the family of Ellsworth Johnson-Bey against a nursing home chain; it’s one of multiple recent efforts by Maryland residents and advocates to target ...

RFK Jr. wants placebo trials for vaccines. A Northwestern researcher says that's unethical.

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Operator: Good day, and welcome to the Bioventus First Quarter 2025 Conference Call. [Operator Instructions] Please note this event is being recorded.